ADC Therapeutics SA (ADCT) Earnings
|
Expand Research on ADCT
| Next EPS Date | 8/11/26 | EPS Growth Rate | +16.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +46.8% | Revenue Growth Rate | +3.9% |
| Average % Move 1-Wk after EPS | +2.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.21 | N/A | N/A | $19.58M | N/A | N/A | N/A | ||
| 5/4/26 | Q126 | -$0.13 | -$0.20 | +$0.07 | $20.85M | $20.04M | N/A |  | | Details | |
| 3/10/26 | Q425 | -$0.09 | -$0.29 | +$0.20 | $23.06M | $19.11M | N/A | | | Details | |
| 11/10/25 | Q325 | -$0.19 | -$0.36 | +$0.17 | $16.43M | $17.98M | N/A | | | Details | |
| 8/12/25 | Q225 | -$0.25 | -$0.39 | +$0.14 | $18.84M | $18.05M | N/A | | | Details | |
| 5/14/25 | Q125 | -$0.22 | -$0.40 | +$0.18 | $23.03M | $17.89M | N/A | | | Details | |
| 3/27/25 | Q424 | -$0.25 | -$0.43 | +$0.18 | $16.91M | $18.85M | N/A | | | Details | |
| 3/20/25 |
Q424 | N/A | -$0.43 | N/A | N/A | $18.85M | N/A | N/A | N/A |
